WO2008088174A1 - The composition comprising swellfish extracts using protease, and a manufacturing method thereof - Google Patents
The composition comprising swellfish extracts using protease, and a manufacturing method thereof Download PDFInfo
- Publication number
- WO2008088174A1 WO2008088174A1 PCT/KR2008/000296 KR2008000296W WO2008088174A1 WO 2008088174 A1 WO2008088174 A1 WO 2008088174A1 KR 2008000296 W KR2008000296 W KR 2008000296W WO 2008088174 A1 WO2008088174 A1 WO 2008088174A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- swellfish
- extract
- manufacturing
- artichoke
- protease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/20—Fish extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to a swellfish extract prepared by using protease, a manufacturing method thereof and a composition for treating hangover which comprises the swellfish extract as an active ingredient.
- alcohol is decomposed by alcohol dehydrogenases to be converted into acetaldehyde which is decomposed to acetic acid.
- Acetaldehyde the high concentrated active compound, can induce sweating, rapid pulse, skin flushing, nausea and vomiting.
- acetaldehyde the metabolite of alcohol, would be the reason of hangover.
- alcohol overdose destroys the balance of metabolic system, resulting in fail in maintaining homeostasis in cells.
- the most easily affected organ by alcohol overdose is the liver. That is, excessive alcohol drinking causes liver function disorder in the long term, for example fatty liver, liver cirrhosis, etc, and causes headache, heavy headness, lack of concentration, heartburn and indigestion in the short term.
- Swellfish contains plenty of proteins along with various amino acids, minerals and vitamins and activates alcohol dehydrogenase in human body to enhance liver detoxication and is effective in preventing alcoholism and in treating hangover.
- swellfish has the effect of reducing cholesterol and lowering high blood pressure, resulting in prevention of adult disease. So, it is the favored food for dietary treatment for such patients before or after surgery or with diabetes or kidney disease. It is described in ⁇ Dongeuebogam' that swellfish warms up the body, invigorates, reduces edema, is effective in treatment of waist and leg pain, has treatment effect on hemorrhoid, and has insecticidal effect.
- artichoke (scientific name: Cynara scolymus) has been used in Europe. Artichoke has been known to have hangover treating effect in addition to the preventive and treatment effect on indigestion and adult disease including coronary artery disease and high blood sugar. European countries and Japan have been in the center of the study on artichoke, especially concerning various biological functions of artichoke and its components .
- Artichoke is native to Mediterranean and is a perennial plant in shape of a thistle flower, only a few times bigger than that. Artichoke grows to 2 meters in height and spreads wide to 1 meter in square.
- Flower bud of artichoke is soft and tastes plain and is nutritious, particularly it has plenty of proteins, vitamin A, vitamin C, calcium, iron, phosphate, saccharides and inulin. Particularly, it contains saccharides functioning like insulin in patients with diabetes, making it as an important medicine. Cynarin component contained in leaves or roots accelerates bile secretion and is effective in the treatment of impaired liver function and gastrointestinal disorder and in regulation of blood cholesterol, so that Lt has been used as a therapeutic agent for arteriosclerosis in Europe.
- artichoke It is also used for the treatment of liver disease and kidney disease, especially effective when protein level in urine is high, owing to its diuretic effect and blood cleaning effect.
- the various functions of artichoke are resulted from the strong anti-oxidation activity of its extract. This strong anti-oxidation activity, particularly, enhances the functions of promoting bile secretion and protecting liver cells.
- artichoke has been proved to have a great lipid absorption inhibitory effect. Artichoke has been proved to be a safe material and classified as GRAS (generally recognized as safe) by FDA, USA.
- the present inventors continued to study to develop a method for preparing a composition for treating hangover with improved health enhancing effect along with excellent hangover treating effect but without side effects. And as a result, the present inventors found out the fact that swellfish extract prepared by using protease had effective ingredients more than that prepared by hot water or alcohol extraction had. And further, the present inventors completed this invention by confirming that swellfish extract containing artichoke as an additional ingredient had superior hangover treating effect triggered by synergy effect, compared with each individual swellfish extract and artichoke extract.
- the present invention provides a manufacturing method of a swellfish extract using protease.
- the present invention also provides a swellfish extract prepared by the method of the above.
- the present invention further provides a pharmaceutical composition for treating hangover which comprises the swellfish extract as an active ingredient.
- the present invention also provides a method for treating hangover comprising the step of administering pharmaceutically effective dose of the swellfish extract to a subject.
- the present invention also provides a use of the swellfish extract for the production of the pharmaceutical composition for treating hangover.
- the present invention also provides a health food for treating hangover which comprises the swellfish extract as an active ingredient.
- the present invention provides a use of the swellfish extract for the production of the health food for treating hangover.
- the swellfish extract prepared by protease of the present invention includes more effective ingredients than the swellfish extract prepared by hot water or alcohol does.
- the swellfish extract additionally containing artichoke has better hangover treating effect than independent swellfish extract or artichoke, and has liver function enhancing effect.
- the swellfish extract of the present invention is a safe natural food without side effects, has excellent hangover treating effect and excellent health enhancing effect.
- Fig. 1 is a graph illustrating the time dependent blood ethanol concentrations after treating the swellfish protease extract containing artichoke.
- Fig. 2 is a graph illustrating the time dependent blood acetaldehyde concentrations after treating the swellfish protease extract containing artichoke.
- ⁇ hangover' indicates the general symptoms shown after alcohol drinking, for example headache, diarrhea, lack of appetite, nausea, vomiting, etc, which generally accompanies the decrease of recognition and locomotion, hematological and hormonal changes.
- ⁇ enzyme reaction product' indicates the swellfish extract containing active ingredients of swellfish which are extracted from swellfish flesh by using protease.
- the present invention provides a manufacturing method of a swellfish extract comprising the following steps:
- the swellfish of step 1) can be torafugu (Takifugu rubripes) or shirosabafugu (Lagocephalus wheeleri Abe) , which can be captured from the nature or by breeding.
- Swellfish is a deadly poisonous fish, so that it can be dangerous unless treated properly. So, only the cook qualified and specialized in swellfish cooking is allowed to cook it. Particularly poisonous intestines have to be eliminated together with head and skin. Only swellfish flesh is preferably used as a material for preparing the swellfish extract.
- the enzyme of step 2) is protease.
- swellfish is not boiled or decocted. Instead, protease that is an enzyme to decompose proteins is used to decompose swellfish flesh to extract every effective ingredient of swellfish. That is, effective ingredients included in swellfish flesh are extracted by using protease as many as possible.
- swellfish flesh is put in a reactor equipped with temperature regulator, to which the same weight of water is added.
- Protease enzyme content: 0.1-0.2%) is preferably added thereto, but the amounts of water and enzyme are not limited thereto.
- the preferable enzyme reaction temperature is approximately 25-50 ° C and particularly 37 ° C is more preferred because the reaction speed of protease is fastest at that temperature, but not always limited thereto.
- the preferably enzyme reaction time is approximately 12-36 hours, but not always limited thereto.
- the distillation of step 3) is preferably performed at 65-100 ° C. If the temperature for distillation is higher than 100 ° C, heat-denaturation of enzyme reaction product might be caused. Therefore, the temperature for distillation is preferably at low temperature which is lower than 100 ° C.
- the distillation preferably continued until the volume of enzyme reaction product becomes 1/3-1/2, but not always limited thereto.
- swellfish is not boiled or decocted but distilled. And, only distillate except the solid material remained after distillation is used. Thus, poisonous materials are automatically excluded and only effective ingredients of swellfish remain in swellfish concentrate. At this time, fish smell can also be eliminated.
- artichoke powder is additionally added to the swellfish extract obtained by the method above, followed by filtration and aging.
- the preferable content of artichoke powder in the swellfish extract is 2 ⁇ 8 q/t, but not always limited thereto. It is preferred to filter the swellfish extract 1 ⁇ 3 hours after the addition of artichoke powder using 1000 ⁇ 1400 mesh net. It is preferred to age the swellfish extract 5 - 20 hours at 40 ⁇ 60 ° C, but not always limited thereto.
- the present invention also provides a swellfish extract prepared by the method of the present invention.
- the present invention further provides a pharmaceutical composition for treating hangover which comprises the swellfish extract as an active ingredient.
- the present inventors investigated through animal tests how differently the swellfish extract prepared by protease could reduce blood alcohol and acetaldehyde, compared with the swellfish extract prepared by hot-water or alcohol.
- Distilled water, swellfish protease extract, swellfish hot-water extract and swellfish ethanol extract were orally administered to rats respectively, then, alcohol was orally administered to the rats.
- Blood samples were taken every hour and ethanol and acetaldehyde concentrations in blood were measured by using a kit.
- the swellfish extracts exhibited no statistically significant reducing effect on blood alcohol but still could lower the blood alcohol, compared with the control.
- the swellfish extracts exhibited statistically significant reducing effect on blood acetaldehyde compared with the control.
- the swellfish protease extract was confirmed to have statistically significant reducing effect on both blood alcohol and acetaldehyde, compared with other swellfish extracts prepared by hot-water or ethanol. Therefore, the swellfish extract prepared by protease of the present invention was proved to have more effective ingredients for treating hangover than others.
- the present inventors also investigated whether the sweLlfish protease extract additionally containing artichoke had better hangover treating effect than individual swellfish extract or artichoke extract.
- the present invention also provides a method for treating hangover comprising the step of administering pharmaceutically effective dose of the swellfish extract to a subject.
- the present invention also provides a use of the swellfish extract for the production of the pharmaceutical composition for treating hangover.
- the pharmaceutical composition can include, in addition to swellfish extract, one or more effective ingredients having the same or similar function to swellfish extract.
- the pharmaceutical composition of the present invention can be administered orally or parenterally and be used in general forms of pharmaceutical formulation.
- the composition of the present invention can be prepared for oral or parenteral administration by mixing with generally used diluents or excipients such as fillers, extenders, binders, wetting agents, disintegrating agents and surfactant.
- Solid formulations for oral administration are tablets, pills, powders, granules and capsules. These solid formulations are prepared by mixing the pharmaceutical composition of the present invention with one or more suitable excipients such as starch, calcium carbonate, sucrose or lactose, gelatin, etc.
- suitable excipients such as starch, calcium carbonate, sucrose or lactose, gelatin, etc.
- lubricants as magnesium stearate and talc can be used.
- Liquid formulations for oral administrations are suspensions, solutions, emulsions and syrups, and the above-mentioned formulations can contain various excipients such as wetting agents, sweeteners, aromatics and preservatives in addition to generally used simple diluents such as water and liquid paraffin.
- Formulations for parenteral administration are sterilized aqueous solutions, water-insoluble excipients, suspensions, emulsions, lyophilized preparations and suppositories.
- Water insoluble excipients and suspensions can contain, in addition to the active compound or compounds, propylene glycol, polyethylene glycol, vegetable oil like olive oil, injectable ester like ethylolate, etc.
- Suppositories can contain, in addition to the active compound or compounds, witepsol, macrogol, tween 61, cacao butter, laurin butter, glycerol, gelatin, etc.
- the therapeutic agent of the present invention can be administered by hypodermic injection, intravenous injection or intramuscular injection.
- the present invention also provides a health food for treating hangover which comprises the swellfish extract as an active ingredient.
- the present invention provides a use of the swellfish extract for the production of the health food for treating hangover.
- the swellfish extract of the present invention can be used as a food additive.
- the swellfish extract can be added as it is or as mixed with other food components according to the conventional method.
- the mixing ratio of active ingredients can be regulated according to the purpose of use (prevention, health enhancement or treatment) .
- the pharmaceutical composition of the present invention is added preferably by up to 15 weight part and more preferably by up to 10 weight part.
- the content can be lower than the above but higher content can be accepted as well since the swellfish extract has been proved to be very safe .
- the swellfish extract can be added to meats, sausages, breads, chocolates, candies, snacks, cookies, pizza, ramyuns, flour products, gums, dairy products including ice cream, soups, beverages, tea, drinks, alcohol drinks and vitamin complex, etc, and in wide sense, almost every food applicable in the production of health food can be included.
- the composition for health beverages of the present invention can additionally include various flavors or natural carbohydrates, etc, like other beverages.
- the natural carbohydrates above can be one of monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xilytole, sorbitol, and erythritol.
- natural sweetening agents such as thaumatin and stevia extract, and synthetic sweetening agents such as saccharin and aspartame can be included as a sweetening agent.
- the swellfish extract of the present invention can include in variety of nutrients, vitamins, minerals, flavors, coloring agents, pectic acid and its salts, alginic acid and its salts, organic acid, protective colloidal viscosifiers, pH regulators, stabilizers, antiseptics, glycerin, alcohols, carbonators which used to be added to soda, etc.
- the swellfish extract of the present invention can also include natural fruit juice, fruit beverages and/or fruit flesh addable to vegetable beverages. All the mentioned ingredients can be added independently or together.
- Example 1 Preparation of swellfish extract ⁇ !-!> Swellfish extract prepared by protease Approximately 5 kg of flesh was separated from cleaned torafugu (Takifugu rubripes) or shirosabafugu
- Experimental Example 1 Hangover treating effect of swellfish protease extract 40 Sprague-Dawley rats were grouped by 10, followed by animal tests examining hangover treating effect. Control group rats were treated with 10 ml/kg of distilled water. Experimental group rats were treated with 10 ml/kg of 100% swellfish extract prepared in Example ⁇ 1-1>, 10 ml/kg of 100% swellfish extract prepared in Example ⁇ l-3> or 10 ml/kg of 100% swellfish extract prepared in Example ⁇ l-4>.
- Sprague-Dawley rats males were allowed to take solid feed and tap water freely and adapted for 4 days. After 18 hours of fasting, the rats were treated with test samples. 30 minutes later, alcohol was orally administered to the rats (3 g/kg) . Blood samples were taken after 1 and 3 hours from the orbits and after 5 hours from the hearts. The blood samples were centrifuged at 3000 rpm for 20 minutes to separate serum. Then, ethanol and acetaldehyde concentrations were measured by using a kit (Roche) . Blood ethanol and blood acetaldehyde measured thereby were presented by w/v% and mg% . The concentrations were changed over the time and the statistic analysis was performed by student t-test (paired, independent) . The experiment was confirmed to be successfully done by observing that the blood alcohol level in the control group not treated with the sample of the present invention was reduced over the time as normally as expected from one hour after alcohol intake (3 g/kg) .
- Samples used for the test were 100% swellfish extract (10 mg/kg) of Example ⁇ 1-1>, 100% artichoke extract (10 mg/kg) of Example ⁇ l-5>, 15% swellfish extract (10 mg/kg) of Example ⁇ l-2> and 100% swellfish extract (10 mg/kg) of Example ⁇ l-2> (6.7 times the 15% extract).
- the group treated with 15% swellfish extract containing artichoke did not exhibit statistically significant hangover treating effect, but blood alcohoL level was reduced over the time compared with those of the groups treated with swellfish extract not containing artichoke and artichoke extract, for example blood alcohol level after one hour of the administration was 0.203 ⁇ 0.026 w/v%, blood alcohol level after 3 hours of the administration was 0.06 ⁇ 0.012 w/v%, and blood alcohol level after 5 hours of the administration was 0.045 ⁇ 0.015 w/v% .
- the group treated with 100% swellfish extract containing artichoke did not exhibit statistically significant effect, either, but blood alcohol level was reduced compared with those of the groups treated with swellfish extract not containing artichoke and artichoke extract, for example blood alcohol level after one hour of the administration was 0.220+0.023 w/v%, blood alcohol level after 3 hours of the administration was 0.071 ⁇ 0.014 w/v%, and blood alcohol level after 5 hours of the administration was 0.074 ⁇ 0.022 w/v%, which was though lower than the levels shown in the group treated with 15% swellfish extract (see Table 2 and Fig. 1) . Blood acetaldehyde level was also investigated in each group.
- blood acetaldehyde level after one hour from the administration was 0.534+0.084 w/v%
- blood acetaldehyde level after 3 hours of the administration was 0.24910.050 w/v%
- blood acetaldehyde level after 5 hours of the administration was 0.154+0.026 w/v%, which were more significant down-regulation than those in the groups treated with swellfish extract not containing artichoke and artichoke extract.
- blood acetaldehyde level after one hour from the administration was 0.275 ⁇ 0.014 w/v%
- blood acetaldehyde level after 3 hours of the administration was 0.158 ⁇ 0.039 w/v%
- blood acetaldehyde level after 5 hours of the administration was 0.128 ⁇ 0.024 w/v%, which were more significant reducing effect than those in the groups treated with swellfish extract not containing artichoke and artichoke extract (see Table 2 and Fig. 2).
- the swellfish protease extract containing artichoke of the present invention was confirmed to have approximately 50% hangover treating effect after 1 and 3 hours of the alcohol administration in the group treated with the 100% extract.
- composition containing the swellfish extract of the present invention as an active ingredient are described hereinafter.
- Powders were prepared by mixing all the above components, which were filled in airtight packs according to the conventional method for preparing powders.
- Magnesium stearate 2 mg Tablets were prepared by mixing all the above components by the conventional method for preparing tablets.
- Lactose 100 mg Magnesium stearate 2 mg Capsules were prepared by mixing all the above components, which were filled in gelatin capsules according to the conventional method for preparing capsules.
- Pills were prepared by mixing all the above components according to the conventional method for preparing pills. Each pill contained 4 g of the mixture.
- Health enhancing seasonings were prepared by mixing 20-95 weight part of the swellfish extract of Example ⁇ 1- 1> with seasonings according to the conventional method.
- Example ⁇ 1-1> was added to flour.
- Health enhancing foods such as bread, cake, cookies, crackers and noodles were prepared with the flour mixture according to the conventional method.
- Brown rice, barley, glutinous rice and Yulmu (Job's tears) were gelatinized according to the conventional method, dried and pulverized to obtain 60-mesh powders.
- Black soybean, black sesame and wild sesame were steamed and dried according to the conventional method and pulverized to obtain 60-mesh powders.
- the swellfish extract of Example ⁇ 1-1> was concentrated under reduced pressure, spray-dried and pulverized to obtain 60-mesh dry powders.
- Sun-Sik was prepared by mixing the dry powders of the grains, seeds and the swellfish extract of Example ⁇ 1-1> according to the below ratio.
- Grains (brown rice: 30 weight part, Yulmu: 15 weight part, barley: 20 weight part) , Seeds (wild sesame: 7 weight part, black soybean: 8 weight part, black sesame: 7 weight part),
- the above constituents were mixed according to the conventional method for preparing health beverages.
- the mixture was heated at 85°C for 1 hour with stirring and then filtered.
- the filtrate was loaded in 2 liter sterilized containers, which were sealed and sterilized again, stored in a refrigerator until they would be used for the preparation of a composition for health beverages.
- the constituents appropriate for favorite beverages were mixed according to the preferred mixing ratio but the composition ratio can be adjusted according to regional and national preferences, etc.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Botany (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009546322A JP2010516669A (en) | 2007-01-19 | 2008-01-17 | Composition comprising pufferfish extract using protease and method for producing the same |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20070006104 | 2007-01-19 | ||
| KR10-2007-0006104 | 2007-01-19 | ||
| KR1020070089038A KR100839586B1 (en) | 2007-01-19 | 2007-09-03 | Composition containing blowfish extract using protease as an active ingredient and method for preparing the same |
| KR10-2007-0089038 | 2007-09-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2008088174A1 true WO2008088174A1 (en) | 2008-07-24 |
Family
ID=39636137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2008/000296 Ceased WO2008088174A1 (en) | 2007-01-19 | 2008-01-17 | The composition comprising swellfish extracts using protease, and a manufacturing method thereof |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2008088174A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112831535A (en) * | 2021-02-04 | 2021-05-25 | 福建省水产研究所(福建水产病害防治中心) | Extraction method and cosmetics of enzyme-hydrolyzed polypeptides from the muscle of chrysanthemum yellow pufferfish |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09509156A (en) * | 1994-02-03 | 1997-09-16 | ケンブリッジ・ニューロサイエンス・インコーポレーテッド | Therapeutic guanidines |
| KR20040025723A (en) * | 2002-09-17 | 2004-03-25 | 김익수 | Anticancer drug composition containing swellfish extract |
| KR20060003503A (en) * | 2004-07-06 | 2006-01-11 | 주식회사 피앤아이 | Polypeptide extract derived from puffer fish and cancer prevention or treatment composition comprising the same |
| EP1645277A1 (en) * | 2003-07-14 | 2006-04-12 | Nanning Maple Leaf Pharmaceutical Co., Ltd. | Stable tetrodotoxin freeze drying medicinal preparation |
-
2008
- 2008-01-17 WO PCT/KR2008/000296 patent/WO2008088174A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09509156A (en) * | 1994-02-03 | 1997-09-16 | ケンブリッジ・ニューロサイエンス・インコーポレーテッド | Therapeutic guanidines |
| KR20040025723A (en) * | 2002-09-17 | 2004-03-25 | 김익수 | Anticancer drug composition containing swellfish extract |
| EP1645277A1 (en) * | 2003-07-14 | 2006-04-12 | Nanning Maple Leaf Pharmaceutical Co., Ltd. | Stable tetrodotoxin freeze drying medicinal preparation |
| KR20060003503A (en) * | 2004-07-06 | 2006-01-11 | 주식회사 피앤아이 | Polypeptide extract derived from puffer fish and cancer prevention or treatment composition comprising the same |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112831535A (en) * | 2021-02-04 | 2021-05-25 | 福建省水产研究所(福建水产病害防治中心) | Extraction method and cosmetics of enzyme-hydrolyzed polypeptides from the muscle of chrysanthemum yellow pufferfish |
| CN112831535B (en) * | 2021-02-04 | 2023-07-07 | 福建省水产研究所(福建水产病害防治中心) | Extraction method and cosmetics of chrysanthemum yellow puffer muscle enzymolysis polypeptide |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104432084B (en) | A kind of conditioning powder and its production and use | |
| KR0126431B1 (en) | Healthy food having effect of falling of blood sugar | |
| US6416795B1 (en) | Herbal extract composition for stress prevention and treatment | |
| US7135199B2 (en) | Alcohol-fermented food or pharmaceutical composition for prevention of obesity and process for preparation thereof | |
| US20020018818A1 (en) | Sugar decomposition inhibitor, digestive enzyme activity inhibitor, insulin secretion controller, and healthy food and beverage | |
| KR20030026939A (en) | The effective tea compositions with guava leaf as chief element for remedy against diabetes, obesity and aging, and functional foods | |
| CN108174951A (en) | A kind of mulberry leaf sealwort tea preparation method of auxiliary hyperglycemic | |
| CN107613998A (en) | Medicinal composition or health functional food for prevention and treatment of metabolic diseases containing Ferula ferulae water extract as an active ingredient | |
| JP2006045212A (en) | Oral composition containing specific quinic acid derivative | |
| CN104824304A (en) | Selenium-enriched chocolate milk candy for old people | |
| CN108041558A (en) | A kind of health soy sauce and preparation method thereof | |
| CN107019136A (en) | A kind of solid beverage with effect of lowering blood sugar and preparation method thereof | |
| KR20130130131A (en) | Vinegar composition fermented with black garlic and preparation method thereof | |
| KR101350046B1 (en) | Vinegar composition fermented with herbal extracts and preparation method thereof | |
| KR100727396B1 (en) | Composition containing a mixture of watermelon rind extract and oxacosanol | |
| WO2008088174A1 (en) | The composition comprising swellfish extracts using protease, and a manufacturing method thereof | |
| KR100496622B1 (en) | Alcohol fermented food or pharmaceutical composition for prevention of obesity and process for preparation thereof | |
| KR20120115471A (en) | A composition comprising boiled powder or extract of glycine soja seed for the prevention and treatment of diabetes mellitus and diabetic complication | |
| WO2005105125A1 (en) | Preventive or remedy for osteroporosis | |
| KR20080079374A (en) | Composition comprising the mixed herbal extract as an active ingredient and a method of manufacturing the same | |
| KR101824217B1 (en) | Food composition with Citrus sinensis L. Osbeck and the extract of Irvingia gabonensis seed for improvement of obesity and hyperlipidemia | |
| KR100484312B1 (en) | Beverage contain aralia continentalis kitagawa | |
| KR101811227B1 (en) | Composition for Immune Enhancement, Fatigue Recovery, Physiologically Active, Detoxification Comprising Extracts of Lycium chinence miller, Rubus coreanus Miq. & Schisandra chinensis | |
| KR102877158B1 (en) | Use of a composition comprising glutinous foxtail millet extract or a fraction thereof for preventing, improving or treating sarcopenia | |
| JP2007070263A (en) | Composition for preventing diabetes mellitus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 200880008939.5 Country of ref document: CN |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08704832 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 2009546322 Country of ref document: JP Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 08704832 Country of ref document: EP Kind code of ref document: A1 |